Browsing Tag
Channel Therapeutics
1 post
What John M. Gay’s CFO appointment means for Pelthos Therapeutics (NYSE American: PTHS) and its next growth phase
Pelthos Therapeutics has named John M. Gay as CFO. Read what the move signals for Zelsuvmi growth, funding strategy, and Pelthos stock now.